1. Home
  2. RYAN vs BMRN Comparison

RYAN vs BMRN Comparison

Compare RYAN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYAN

Ryan Specialty Holdings Inc.

N/A

Current Price

$41.91

Market Cap

10.8B

Sector

Finance

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$66.53

Market Cap

13.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYAN
BMRN
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
13.0B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
RYAN
BMRN
Price
$41.91
$66.53
Analyst Decision
Buy
Buy
Analyst Count
17
18
Target Price
$50.88
$88.22
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.77
Revenue
$3,051,126,000.00
$1,313,646,000.00
Revenue This Year
$15.78
$15.02
Revenue Next Year
$12.49
$12.23
P/E Ratio
$86.72
$86.55
Revenue Growth
21.28
17.62
52 Week Low
$29.28
$49.26
52 Week High
$59.19
$70.98

Technical Indicators

Market Signals
Indicator
RYAN
BMRN
Relative Strength Index (RSI) 46.96 56.83
Support Level $40.43 $58.03
Resistance Level $43.10 $70.98
Average True Range (ATR) 1.33 1.56
MACD -0.23 -0.34
Stochastic Oscillator 25.36 46.31

Price Performance

Historical Comparison
RYAN
BMRN

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: